J J.
Long term subscriber, cancelling subscription…
I have been a subscriber to "Doc" Eifrig's income/retirement newsletter since about 2008. At first, the information wasn't too bad and several of his recommendations did fairly well. Unfortunately, as time went on his picks got less and less profitable. There seemed to be a pattern of making recommendations at or near the top of a long upward run. Maybe it's not the case, I can't prove it, but it sure looks like the low cost accounts are being used as buyers to provide an exit market for the stocks they recommend in their higher cost services. I still get the newsletter, but hardly ever use his suggestions, and when I do it usually results in a 15 to 20% loss. Pretty much everything Doc recommends underperforms. Most recently his pick of BTI(British Tobacco) was made on the day the stock peaked at $59.29 and since has dropped steadily to the current $51.19 for a loss of almost 14%. His MLP recommendations got me in an expensive tax nightmare in my SEP-IRA. The only reason I get it is that as an early subscriber it is very inexpensive and does seem to give a little economic information here and there. Since I seldom read his monthly newsletters anymore, I will be cancelling the auto renew on my account.
Response from Stansberry ResearchNov 3, 2025
Thank you for your feedback and for being a subscriber since 2008. We value your long-term support and are sorry to hear that you’ve been disappointed with some recent recommendations. At Stansberry Research, we’re guided by two principles: to share the information we’d want if our roles were reversed, and to only publish analysts whose advice we’d want our own families to follow. Your feedback matters to us, and we’d like to learn more. Please contact our Member Services Team at [email protected] or call (888) 261-2693.